Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Active not recruiting 3 Recruiting 2 Withdrawn 1 Unknown 1 Terminated 1 Available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 3 Multiple Myeloma 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Glioblastoma 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Triple Negative Breast Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Richter's Transformation 1 Recurrence 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neoplasms, Plasma Cell 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Liver Neoplasms 1 Glioma 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Castration Levels of Testosterone 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1

Interventions

Rituximab 67 Cyclophosphamide 41 fludarabine phosphate 17 Etoposide 17 Doxorubicin 17 Vincristine 16 Prednisone 16 Filgrastim 14 Mycophenolic Acid 13 Cyclosporine 13 Lenalidomide 12 Antilymphocyte Serum 12 Gemcitabine 11 Radiotherapy 10 fludarabine 9 Peripheral Blood Stem Cell Transplantation 9 Methotrexate 9 Whole-Body Irradiation 8 Tacrolimus 8 Melphalan 8 Carboplatin 8 Bortezomib 8 venetoclax 7 Dexamethasone 7 Cord Blood Stem Cell Transplantation 7 Busulfan 7 ibritumomab tiuxetan 6 Ifosfamide 6 Flow Cytometry 6 obinutuzumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lymphoma, Large B-Cell, Diffuse × selinexor × Clear all

NCT05265975 2025-06-09

SWATCH

Antengene Corporation

Phase 1/2 Terminated

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡